Structure-activity relationships of a potent and selective Ca2+ Receptor antagonist.

被引：0
|
作者：
Callahan, JF
Barton, L
Bryan, WM
Burgess, JL
DelMar, R
Fox, J
Gleason, JG
Gorycki, P
Gowen, M
Huffman, WF
Lago, AM
Nemeth, E
Nguyen, TT
Smith, BR
Stroup, G
Bhatnagar, PK
机构：
[1] SmithKline Beecham, Med Chem, Collegeville, PA 19426 USA
[2] SmithKline Beecham, DMPK, Collegeville, PA USA
[3] SmithKline Beecham, Bone & Cartilage Biol, Collegeville, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
200-MEDI
引用
收藏
页码：U35 / U35
页数：1
相关论文
共 50 条
  • [21] MT2 selective melatonin receptor antagonists:: design and structure-activity relationships
    Rivara, Silvia
    Mor, Marco
    Lorenzi, Simone
    Lodola, Alessio
    Plazzi, Pier Vincenzo
    Spadoni, Gilberto
    Bedini, Annalida
    Tarzia, Giorgio
    ARKIVOC, 2006, : 8 - 16
  • [22] Selective angiotensin II AT2 receptor agonists:: Benzamide structure-activity relationships
    Wallinder, Charlotta
    Botros, Milad
    Rosenstrom, Ulrika
    Guimond, Marie-Odile
    Beaudry, Helene
    Nyberg, Fred
    Gallo-Payet, Nicole
    Hallberg, Anders
    Alterman, Mathias
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (14) : 6841 - 6849
  • [23] Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor
    Richardson, TI
    Ornstein, PL
    Briner, K
    Fisher, MJ
    Backer, RT
    Biggers, CK
    Clay, MP
    Emmerson, PJ
    Hertel, LW
    Hsiung, HM
    Husain, S
    Kahl, SD
    Lee, JA
    Lindstrom, TD
    Martinelli, MJ
    Mayer, JP
    Mullaney, JT
    O'Brien, TP
    Pawlak, JM
    Revell, KD
    Shah, J
    Zgombick, JM
    Herr, RJ
    Melekhov, A
    Sampson, PB
    King, CHR
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) : 744 - 755
  • [24] Structure-activity relationships of astemizole derivatives for inhibition of store operated Ca2+ channels and exocytosis
    Fischer, MJE
    Paulussen, JJC
    Tollenaere, JP
    De Mol, NJ
    Janssen, LHM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (2-3) : 353 - 361
  • [25] Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist
    Bennett, MA
    Murray, TF
    Aldrich, JV
    JOURNAL OF PEPTIDE RESEARCH, 2005, 65 (03): : 322 - 332
  • [26] Synthesis and structure-activity relationships of potent retinoid X receptor ligands.
    Jeong, S
    Farmer, LJ
    CananKoch, SS
    Nadzan, AM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 66 - MEDI
  • [27] Pyrazolo Derivatives as Potent Adenosine Receptor Antagonists: An Overview on the Structure-Activity Relationships
    Cheong, Siew Lee
    Venkatesan, Gopalakrishnan
    Paira, Priyankar
    Jothibasu, Ramasamy
    Mandel, Alexander Laurence
    Federico, Stephanie
    Spalluto, Giampiero
    Pastorin, Giorgia
    INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2011, 2011
  • [28] Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist
    Kassack, MU
    Braun, K
    Ganso, M
    Ullmann, H
    Nickel, P
    Böing, B
    Müller, G
    Lambrecht, G
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2004, 39 (04) : 345 - 357
  • [29] Structure-Activity Relationships of hNPFF2 Receptor
    Rathmann, Rd
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 166 - 167
  • [30] Selective ET(A) receptor antagonists. Merging of two moderately active series into a potent, selective ET(A) receptor antagonist.
    Astles, PC
    Harris, NV
    Harper, MF
    Lewis, R
    Majid, T
    McCarthy, C
    McLay, I
    Porter, B
    Smith, C
    Walsh, RJA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 20 - MEDI
12345